Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CollaRx gentamicin surgical implant: Phase III started

Innocoll began a U.S. Phase III trial in 1,000-1,500 diabetic and/or

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE